Close
Top Videos
Top Searches
Moods
Black Lives Matter
Chill
Christmas
Commute
Energy boosters
Feel-Good
Focus
Party
Pride
Romance
Sad
Sleep
Workout
Genres
African
Arabic
Blues
Bollywood & Indian
Christian & Gospel
Classical
Country and Americana
Dance and electronic
Decades
Family
Folk and acoustic
Hip-hop
Indie and alternative
J-Pop
Jazz
K-Pop
Latin
Mandopop & Cantopop
Metal
Pop
R&B and Soul
Reggae and Caribbean
Rock
Soundtracks and musicals
Dr Glenn Nielsen - Motor FND: recent advances and future directions
28:50
|
Download MP3
Related Videos
33:43
Prof Richard K. Burt - 'Haemopoietic stem cell transplantation in the management of MS'
28:12
Dr E Ann Yeh - Longer-term safety of B-cell therapies in MS
25:34
Professor Peter Libby
25:24
Professor John McMurray - Heart failure: pharmacology that extends the limits!
26:44
Professor Katy Rezvani - CAR-NK therapy
38:55
Professor Milton Packer - 'Heart failure – are there limits to anti-diabetic therapy with SGLT2'
26:50
Professor Alice Cheng - SGLT inhibitors - are there no therapeutic limits
35:24
Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'
33:47
Prof Jon Stone - Functional Neurological Disorder & MS - looking for a treatable cause of disability
40:32
Professor John Deanfield - Primordial cardiology in youth – what are the limits? (English)
25:43
Professor Perry Elliott - Sudden cardiac death at the limits
28:50
Dr Glenn Nielsen - Motor FND: recent advances and future directions
0:33
Cardiology, Diabetes & Nephrology At the Limits 2023 | Available to view now
23:49
Professor Carel le Roux - 'How the gut talks to the brain and protects the heart and kidneys'
29:48
Professor John McMurray - Heart failure therapy – extending the limits!
24:49
Professor Sadaf Farooqi - The science of obesity, where might this lead clinical practice?
41:36
Dr David Rog - PML in MS
33:29
Professor Malcolm K Brenner - Overview of cell therapy for cancer in 2022 and beyond
37:00
Professor David Clifford - 'PML and multiple sclerosis'
23:18
Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome?